US Stock MarketDetailed Quotes
CHRO Channel Therapeutics
- 0.631
- +0.012+1.94%
Close Nov 21 16:00 ET
- 0.589
- -0.042-6.72%
Post 19:55 ET
3.80MMarket Cap-364P/E (TTM)
0.665High0.510Low53.89KVolume0.649Open0.619Pre Close31.05KTurnover3.40%Turnover RatioLossP/E (Static)6.03MShares6.00052wk High-2.66P/B1.00MFloat Cap0.45052wk Low--Dividend TTM1.59MShs Float6.000Historical High--Div YieldTTM25.05%Amplitude0.450Historical Low0.576Avg Price1Lot Size
About Channel Therapeutics Company
Channel Therapeutics Corp. is a clinical-stage biotech company that engages in the development and commercialization of new therapeutics to alleviate pain. The company was founded on November 18, 2024 and is headquartered in Freehold, NJ.
Company Profile
SymbolCHRO
Company NameChannel Therapeutics
Listing DateFeb 16, 2024
Issue Price6.00
CEOMr. Francis Knuettel, II
MarketAMEX
Employees8
Fiscal Year Ends12-31
Address4400 Route 9 South,Suite 1000
CityFreehold
ProvinceNew Jersey
CountryUnited States of America
Zip Code07728
Phone1-877-265-8266
Websitehttps://www.chromocell.com
Company Executives
- Name
- Position
- Salary
- Francis Knuettel, II
- Chief Executive Officer, Chief Financial Officer, Treasurer and Secretary
- 307.01K
- Dr. Eric Lang, PhD
- Chief Medical Officer
- 287.50K
- Todd C. Davis
- Chairman of the Board
- 748.04K
- Chia-Lin Simmons
- Independent Director
- 336.61K
- Ezra M. Friedberg
- Independent Director
- 374.02K
- Dr. Richard Malamut
- Independent Director
- 374.02K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
